Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ware

Showing results (631-640 of 721) with videos related to

Pageof 73
Sort By:
American Journal of Human Genetics|August 31, 2023
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findingsKathryn A McGurk, Xiaolei Zhang, Pantazis Theotokis, et al.
The Pediatric Infectious Disease Journal|April 27, 2022
Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled TrialGabrielle B McCallum, Siew M Fong, Keith Grimwood, et al.
Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of <i>MYBPC3</i> Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
The Pediatric Infectious Disease Journal|June 3, 2024
Twenty-four Month Outcomes of Extended- Versus Standard-course Antibiotic Therapy in Children Hospitalized With Pneumonia in High-risk Settings: A Randomized Controlled TrialHing C Kok, Gabrielle B McCallum, Stephanie T Yerkovich, et al.
Archives of Disease in Childhood|May 9, 2025
Association between hospitalised childhood pneumonia and follow-up chest radiographs in high-risk populations: a secondary analysis of a multicentre randomised controlled trialHing Cheong Kok, Stephanie T Yerkovich, Gabrielle B McCallum, et al.
Journal of the American Heart Association|September 11, 2025
Fibrosis Entropy Is Associated With Life-Threatening Arrhythmia in Nonischemic CardiomyopathyDaniel J Hammersley, Hassan A Zaidi, Richard E Jones, et al.
European Journal of Heart Failure|September 20, 2023
Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathyDaniel J Hammersley, Richard E Jones, Ruth Owen, et al.
BMJ Open|May 28, 2026
Strong Families Study: protocol for a co-designed birth cohort study with Aboriginal and Torres Strait Islander families in Queensland, AustraliaSalma Mohamed Ahmed, Emily S Dorey, Davina Smith, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2018
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert PanelMelissa A Kelly, Colleen Caleshu, Ana Morales, et al.
Pageof 73

Showing results (631-640 of 721) with videos related to

Sort By:
Pageof 73
American Journal of Human Genetics|August 31, 2023
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findingsKathryn A McGurk, Xiaolei Zhang, Pantazis Theotokis, et al.
The Pediatric Infectious Disease Journal|April 27, 2022
Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled TrialGabrielle B McCallum, Siew M Fong, Keith Grimwood, et al.
Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of <i>MYBPC3</i> Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
The Pediatric Infectious Disease Journal|June 3, 2024
Twenty-four Month Outcomes of Extended- Versus Standard-course Antibiotic Therapy in Children Hospitalized With Pneumonia in High-risk Settings: A Randomized Controlled TrialHing C Kok, Gabrielle B McCallum, Stephanie T Yerkovich, et al.
Archives of Disease in Childhood|May 9, 2025
Association between hospitalised childhood pneumonia and follow-up chest radiographs in high-risk populations: a secondary analysis of a multicentre randomised controlled trialHing Cheong Kok, Stephanie T Yerkovich, Gabrielle B McCallum, et al.
Journal of the American Heart Association|September 11, 2025
Fibrosis Entropy Is Associated With Life-Threatening Arrhythmia in Nonischemic CardiomyopathyDaniel J Hammersley, Hassan A Zaidi, Richard E Jones, et al.
European Journal of Heart Failure|September 20, 2023
Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathyDaniel J Hammersley, Richard E Jones, Ruth Owen, et al.
BMJ Open|May 28, 2026
Strong Families Study: protocol for a co-designed birth cohort study with Aboriginal and Torres Strait Islander families in Queensland, AustraliaSalma Mohamed Ahmed, Emily S Dorey, Davina Smith, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2018
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert PanelMelissa A Kelly, Colleen Caleshu, Ana Morales, et al.
Pageof 73